Journal of Cancer Therapy
Vol.4 No.8A(2013), Paper ID 36108, 7
pages
DOI:10.4236/jct.2013.48A005
Effects of ADH1C, ALDH2, and CYP2A6 Polymorphisms on Individual Risk of Tobacco-Related Lung Cancer in Male Japanese Smokers
Makiko Shimizu, Yuki Ishii, Maho Okubo, Hideo Kunitoh, Tetsuya Kamataki, Hiroshi Yamazaki
Showa Pharmaceutical University, Machida, Tokyo, Japan
Showa Pharmaceutical University, Machida, Tokyo, Japan
Showa Pharmaceutical University, Machida, Tokyo, Japan
Mitsui Memorial Hospital, Chiyoda-ku, Tokyo, Japan
Showa Pharmaceutical University, Machida, Tokyo, Japan
Showa Pharmaceutical University, Machida, Tokyo, Japan
Copyright © 2013 Makiko Shimizu, Yuki Ishii, Maho Okubo, Hideo Kunitoh, Tetsuya Kamataki, Hiroshi Yamazaki et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Shimizu, M. , Ishii, Y. , Okubo, M. , Kunitoh, H. , Kamataki, T. and Yamazaki, H. (2013) Effects of ADH1C, ALDH2, and CYP2A6 Polymorphisms on Individual Risk of Tobacco-Related Lung Cancer in Male Japanese Smokers.
Journal of Cancer Therapy,
4, 29-35. doi:
10.4236/jct.2013.48A005.